Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine

• Main Authors: Juanhong Zhang, Yuyan Chen, Yuemei Sun, Rong Wang, Junmin Zhang, Zhengping Jia
• Format: Article
• Language: English
• Published: Taylor & Francis Group 2018-01-01
• Series: Drug Delivery
• Subjects: nifedipine; gut microbiota; metabolic activity; plateau hypoxia; bioavailability; pharmacokinetics
• Online Access: http://dx.doi.org/10.1080/10717544.2018.1469687
• ISSN: 1071-7544; 1521-0464

Nifedipine is completely absorbed by the gastrointestinal tract and its pharmacokinetics and metabolism may be influenced by microorganisms. If gut microbes are involved in the metabolism of nifedipine, plateau hypoxia may regulate the bioavailability and the therapeutic effect of nifedipine by altering the metabolic activity of the gut microbiota. We herein demonstrated for the first time that gut flora is involved in the metabolism of nifedipine by in vitro experiments. In addition, based on the results of 16S rRNA analysis of feces in rats after acute plateau, we first confirmed that the plateau environment could cause changes in the number and composition of intestinal microbes. More importantly, these changes in flora could lead to a slower metabolic activity of nifedipine in the body after an acute plateau, resulting in increased bioavailability and therapeutic efficacy of nifedipine. Our research will provide basis and new ideas for changes in the fecal flora of human acutely entering the plateau, and contribute to rational drug use of nifedipine.